Name: Enanta Pharmaceuticals, Inc. (ENTA) Balance Sheet
Creator: FinSpry

Enanta Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Enanta Pharmaceuticals, Inc. (ENTA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018
Current Assets
Cash and Cash Equivalents	32.30	37.23	85.39	43.99	244.00	386.65	335.24	308.73
Short-Term Investments	156.57	210.95	284.52	205.24	186.80	0.00	0.00	0.00
Cash & Short-Term Investments	188.86	248.19	369.91	249.23	244.00	386.65	335.24	308.73
Accounts Receivable	6.88	6.65	8.61	20.32	60.83	36.53	51.31	67.21
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	8.59	12.41	13.26	13.45	0.62	0.84	1.65	0.00
Total Current Assets	204.34	299.85	422.79	311.71	319.02	436.84	401.85	380.39
Non-Current Assets
Property, Plant & Equipment (Net)	72.94	73.35	34.71	29.75	10.65	15.62	19.55	8.37
Long-Term Investments	3.36	0.00	0.00	29.29	108.42	0.00	0.00	0.00
Other Non-Current Assets	0.09	3.45	4.77	4.66	0.70	0.70	0.70	0.70
Total Non-Current Assets	76.40	76.80	39.48	63.70	119.77	49.30	96.60	33.84
Total Assets	280.73	376.65	462.28	375.41	438.79	486.13	489.83	414.23
Current Liabilities
Accounts Payable	1.95	8.00	4.10	6.00	31.97	19.90	22.61	16.03
Short-Term Debt	37.00	34.46	35.08	0.00	0.00	0.00	0.00	0.00
Current Portion of Long-Term Debt	30.71	34.46	35.08	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	12.75	13.55	18.34	20.94	22.43	0.00	0.00	0.00
Other Current Liabilities	9.61	34.46	35.08	6.44	6.09	4.78	1.63	0.00
Total Current Liabilities	48.56	57.54	62.79	29.83	36.17	24.16	22.61	16.03
Non-Current Liabilities
Long-Term Debt	167.20	53.94	21.24	22.37	1.13	3.84	0.00	0.29
Other Non-Current Liabilities	0.26	135.01	160.09	0.45	0.56	1.08	3.10	1.79
Total Non-Current Liabilities	167.46	190.30	182.75	24.25	3.19	6.40	4.73	4.52
Total Liabilities	216.02	247.84	245.54	54.08	39.36	30.55	27.34	20.55
Stockholders' Equity
Common Stock	0.21	0.21	0.21	0.21	0.20	0.00	0.00	0.00
Retained Earnings	-404.93	-323.04	-207.00	-73.18	48.19	128.42	163.74	117.36
Accumulated Other Comprehensive Income	-0.34	0.30	-1.17	-3.72	-0.38	0.00	0.15	-0.40
Additional Paid-in Capital	469.77	451.34	424.69	398.03	351.03	326.96	298.41	276.53
Shares Outstanding	21.39	21.19	21.06	20.79	0.00	0.00	0.00	0.00
Total Stockholders' Equity	64.72	128.81	216.74	321.33	399.43	455.58	462.49	393.68
Total Liabilities & Equity	280.73	376.65	462.28	375.41	438.79	486.13	489.83	414.23